Form D · Other Health Care
INTELLIGENT BIO SOLUTIONS INC.
New York, NY · CIK 0001725430
Offering snapshot reported Sep 14, 2026 · SEC filing
- Reported sold
- $4.98M Offering amount: $4.98M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 31, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2026 | Initial | $4,979,631 | No comparison | 1 | SEC filing |
| Jan 13, 2026 | Initial | $9,978,059 | No comparison | 2 | SEC filing |
| Aug 11, 2025 | Initial | $3,839,356 | No comparison | 7 | SEC filing |
| Mar 22, 2024 | Initial | $10,100,683 | No comparison | 8 | SEC filing |
| Oct 18, 2022 | Initial | $0 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $400K
- Finders' fees
- $0
- Form D file number
- 021-597341
Offering closed September 2, 2026
Ladenburg received $399,999.83 in commission, a $49,999.98 management fee, $60,000 expense reimbursement, and warrants for 101,832 shares of common stock. Ladenburg also receives 9% commission on gross proceeds from Series N-1 and N-2 Warrant exercises.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ladenburg Thalmann & Co. Inc. | 505 |
Source: Form D, filed Sep 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Boyages | Director |
| Lawrence Fisher | Director |
| Nicola Fraser | Director |
| Jonathan Hurd | Director |
| Jason Isenberg | Director |
| George Margelis | Director |
| Spiro Sakiris | Executive |
| Harry Simeonidis | Executive |
| Christopher Towers | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
135 West 41st Street 5th Floor
New York, NY, 10036
New York, NY, 10036